Please see below for a list of search results.
The HTA’s high-level aims, objectives and key milestones and deliverables for 2018/19 are set out in this section. This information is supported by our key performance indicators (KPIs) and performance indicators (PIs), which set out how we will measure whether we are achieving those aims.
During 2017, the HTA undertook a fundamental review of its strategy. This exercise gave us considerable reassurance that the public and professionals think we are on the right track with our regulatory approach.
The HTA is an executive Non-Departmental Public Body sponsored by the Department of Health and Social Care, established by the Human Tissue Act 2004.
Cord blood has been shown to contain ‘stem cells’. Stem cells are immature cells that have the potential to develop into different cell types. There are various conditions for which a cord blood stem cell transplant may be used, and there are also many potential uses under investigation.